Ledger.Open graph →
SEC Form D · Amendment · filed July 28, 2020

Aspargo Laboratories, Inc

Offering
$8.5M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
ENGLEWOOD CLIFFS, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Michael Demurjian · Red Bank, NJExec · Director · PromoterMichael Rice · Englewood, NJDirectorFred Biehl · Roseland, NJDirectorDean Stathakis · Huntington Beach, CADirectorTodd Cash · Gilbert, AZDirectorHelios Capital Management LLC · Dover, DEExec · Director · PromoterKwame Ennin · Dallas, TXDirectorChip Zahn · Dallas, TXDirectorRobert Zalewski · Oxford, MIExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗